Valuation: Novartis AG

Market Cap 282B 247B 229B 211B 399B 26,989B 406B 2,730B 1,071B 13,254B 1,059B 1,036B 45,771B P/E 2026 *
21.5x
P/E 2027 * 18.2x
Enterprise Value 314B 275B 255B 235B 444B 30,054B 453B 3,040B 1,192B 14,759B 1,179B 1,153B 50,970B EV / Sales 2026 *
5.52x
EV / Sales 2027 * 5.15x
Free-Float
91.66%
Yield 2026 *
2.86%
Yield 2027 * 2.95%
1 day+0.27%
1 week-0.42%
Current month-1.58%
1 month+3.63%
3 months+3.28%
6 months+9.63%
Current year+13.67%
1 week 123.14
Extreme 123.14
127.24
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
05-18Sell -5,200 0.0003%
05-04Sell 6,800 0.0003%
02-17Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%-0.42%+29.19%+47.26% 282B
-0.10%-1.09%+48.50%+173.06% 1,060B
+0.42%-0.53%+64.49%+62.43% 619B
-0.32%-2.94%+29.10%+85.09% 438B
-1.75%-0.33%+28.33%+23.58% 333B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-1.03%-1.92%+21.00%+57.87% 196B
+0.78%+0.92%+16.70%+70.52% 161B
+1.14%+2.93%-3.69%-32.29% 138B
Average -0.12%-3.06%+22.51%+47.16% 371.17B
Weighted average by Cap. -0.16%-3.00%+34.23%+79.85%

Financials

2026 *2027 *
Net sales 56.85B 49.86B 46.18B 42.49B 80.37B 5,441B 81.94B 550B 216B 2,672B 213B 209B 9,228B 60.27B 52.86B 48.96B 45.05B 85.21B 5,769B 86.87B 584B 229B 2,833B 226B 221B 9,783B
Net income 14.08B 12.35B 11.44B 10.52B 19.9B 1,348B 20.29B 136B 53.46B 662B 52.87B 51.71B 2,285B 15.64B 13.72B 12.71B 11.69B 22.12B 1,497B 22.55B 151B 59.4B 735B 58.74B 57.46B 2,539B
Net Debt 32.03B 28.09B 26.02B 23.94B 45.28B 3,065B 46.16B 310B 122B 1,505B 120B 118B 5,198B 28.54B 25.03B 23.18B 21.33B 40.35B 2,731B 41.13B 276B 108B 1,341B 107B 105B 4,632B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
13/07/26 CHF 124.58 +0.24% 2,143,959
10/07/26 CHF 124.28 -0.02% 2,334,841
09/07/26 CHF 124.30 -1.27% 2,233,204
08/07/26 CHF 125.90 -0.71% 2,243,169
07/07/26 CHF 126.80 +1.36% 2,306,045
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
154.04USD
Average target price
153.66USD
Spread / Average Target
-0.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock